8-K/A - ABVC BioPharma, Inc. | StockGist

Current Report Details

Event Type

Securities Issuance

Exhibits Only

Disclosure

Amendment

Variant

8-K/A

Items Reported

3.02

Unregistered Sales of Equity Securities. We previously reported that between April 11, 2025, and May 27, 2025, the Company sold an aggregate of 1,987,557 shares

Securities Issuance

$1.3M$2.3M$1.00$1.95

9.01

Exhibits (d) Exhibits Exhibit No. Description 4.2 Form of Voting Rights Proxy Agreement (incorporated by reference to the Current Report on Form 8-K filed on Ap

Exhibits Only

Exhibits (1)

8-K/A

AMENDMENT NO. 1 TO FORM 8-K